Patents by Inventor Otto Gaa
Otto Gaa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10716504Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.Type: GrantFiled: August 28, 2017Date of Patent: July 21, 2020Assignee: Roche Diabetes Care, Inc.Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
-
Patent number: 9869679Abstract: Methods are provided for photometrically determining/detecting sample application to an analytical test element for use with a blood glucose measuring device, where the method includes obtaining a sequence of reflectance readings from the test element with the measuring device, including a blank value prior to sample application, and then monitoring changes of the reflectance readings from the test element with respect to a sample application condition defined by a limit for a reflectance decrease or a reflectance threshold. The methods also can include adjusting the sample application condition in accordance with a drift correction and can include determining an analyte concentration in the body fluid sample. In addition, photometric blood glucose measuring devices are provided that incorporate the methods disclosed herein.Type: GrantFiled: March 5, 2015Date of Patent: January 16, 2018Assignee: Roche Diabetes Care, Inc.Inventors: Gertrud Albrecht, Otto Gaa, Robert Lorenz, Frank Rueckert
-
Publication number: 20170357766Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.Type: ApplicationFiled: August 28, 2017Publication date: December 14, 2017Inventors: Nicole BERNINI, Harvey B. BUCK, JR., Andreas EBERHART, Sybille FROECH, Otto GAA, Michael MARQUANT, Juergen RASCH-MENGES, Bernd ROESICKE, Joerg SCHERER
-
Patent number: 9773093Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.Type: GrantFiled: August 7, 2015Date of Patent: September 26, 2017Assignee: ROCHE DIABETES CARE, INC.Inventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
-
Publication number: 20170251922Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.Type: ApplicationFiled: April 13, 2017Publication date: September 7, 2017Applicant: Roche Diagnostics Operations, Inc.Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
-
Patent number: 9636049Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.Type: GrantFiled: November 11, 2013Date of Patent: May 2, 2017Assignee: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
-
Publication number: 20160108391Abstract: Dry reagent compositions are disclosed that include one or more of an enzyme such as a dehydrogenase, a redox cofactor, an agent capable of eliciting at least one measurable change in a property of an indicator reagent in the presence of redox equivalents, an indicator reagent, and a pyridine-carboxylic acid, derivative or salt thereof. Also provided are diagnostic test elements including the reagent compositions for use in body fluid analysis. Further provided are methods of making test elements, as well as methods of body fluid analysis with such test elements. In the compositions, the pyridine-carboxylic acid, derivative or salt thereof attenuates, reduces or prevents a decrease of enzymatic activity of the at least one dehydrogenase under dry and/or humid conditions.Type: ApplicationFiled: November 9, 2015Publication date: April 21, 2016Applicant: ROCHE DIABETES CARE, INC.Inventors: Gabriele Chemnitius, Thomas Nagel, Otto Gaa, Karl Recht
-
Publication number: 20150356264Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.Type: ApplicationFiled: August 7, 2015Publication date: December 10, 2015Inventors: Nicole BERNINI, Harvey B. BUCK, JR., Andreas EBERHART, Sybille FROECH, Otto GAA, Michael MARQUANT, Juergen RASCH-MENGES, Bernd ROESICKE, Joerg SCHERER
-
Patent number: 9101306Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.Type: GrantFiled: September 22, 2011Date of Patent: August 11, 2015Assignees: Roche Diagnostics Operations, Inc., Roche Diagnostics International AGInventors: Nicole Bernini, Harvey B. Buck, Jr., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
-
Publication number: 20150177257Abstract: Methods are provided for photometrically determining/detecting sample application to an analytical test element for use with a blood glucose measuring device, where the method includes obtaining a sequence of reflectance readings from the test element with the measuring device, including a blank value prior to sample application, and then monitoring changes of the reflectance readings from the test element with respect to a sample application condition defined by a limit for a reflectance decrease or a reflectance threshold. The methods also can include adjusting the sample application condition in accordance with a drift correction and can include determining an analyte concentration in the body fluid sample. In addition, photometric blood glucose measuring devices are provided that incorporate the methods disclosed herein.Type: ApplicationFiled: March 5, 2015Publication date: June 25, 2015Applicant: Roche Diabetes Care, Inc.Inventors: Gertrud Albrecht, Otto Gaa, Robert Lorenz, Frank Rueckert
-
Publication number: 20140363835Abstract: Dry reagent compositions are disclosed for maintaining and preserving enzymatic activity. Also disclosed are test elements incorporating the same and methods of making and using the same for determining the presence or amount of an analyte in a body fluid sample. The dry reagent compositions can include components such as a dehydrogenase, a redox cofactor, an agent capable of eliciting at least one optical change in an optical property of an indicator reagent in the presence of redox equivalents, an indicator reagent, and at least one compatible solute being ectoine or a derivative thereof.Type: ApplicationFiled: August 22, 2014Publication date: December 11, 2014Inventors: Gabriele Chemnitius, Otto Gaa, Thomas Nagel, Karl Recht
-
Patent number: 8721544Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.Type: GrantFiled: March 20, 2008Date of Patent: May 13, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhäuser, Michael Schoemaker, Martin Mueri
-
Publication number: 20140066730Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.Type: ApplicationFiled: November 11, 2013Publication date: March 6, 2014Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
-
Publication number: 20120245438Abstract: A medical system is disclosed, which can be useable in particular for monitoring and/or controlling at least one bodily function of a user. The medical system comprises a control device and at least one medical user element embodied separately from the control device. The medical user element and the control device are designed to exchange data wirelessly. The medical system is designed to enable an automatic assignment step, wherein an exchange of personal data between the medical user element and the control device is enabled by the automatic assignment step. The medical system is furthermore designed to automatically initiate the automatic assignment step by means of an assignment coupling between the medical user element and the control device. The medical system is furthermore designed to enable a separation of the assignment coupling for medical operation of the medical system after the assignment step.Type: ApplicationFiled: September 22, 2011Publication date: September 27, 2012Inventors: Nicole Bernini, Harvey B. Buck, JR., Andreas Eberhart, Sybille Froech, Otto Gaa, Michael Marquant, Juergen Rasch-Menges, Bernd Roesicke, Joerg Scherer
-
Patent number: 7736904Abstract: The present invention pertains to a method for verifying usability of a test element on the basis of the relation of at least one control parameter measurable from the blank test field of a test element to a standard value for the at least one control parameter. In one embodiment, the method comprises determining the deviation between a first ratio calculated from a blank-field reference value measured for the control parameter and a first standard value, and a second ratio calculated from a blank-field control value and the first standard value, and rejecting a test element if the deviation is not within a predetermined tolerance range for the deviation.Type: GrantFiled: January 25, 2008Date of Patent: June 15, 2010Assignee: Roche Diagnostics Operations, Inc.Inventors: Otto Gaa, Gertrud Albrecht, Dieter Loch-Leroux
-
Publication number: 20100144042Abstract: The invention concerns a method for automatically differentiating between a sample liquid and a control liquid especially within the context of analytical measuring systems, wherein the presence of a special property of the control liquid and/or at least two criteria are used for the differentiation. In addition the invention concerns appropriate control liquids that are suitable for the new method.Type: ApplicationFiled: February 15, 2010Publication date: June 10, 2010Inventors: Guenter Frey, Carina Horn, Otto Gaa, Hans Kintzig, Hans-Ruediger Murawski
-
Patent number: 7670846Abstract: The invention concerns a method for automatically differentiating between a sample liquid and a control liquid especially within the context of analytical measuring systems, wherein the presence of a special property of the control liquid and/or at least two criteria are used for the differentiation. In addition the invention concerns appropriate control liquids that are suitable for the new method.Type: GrantFiled: June 24, 2003Date of Patent: March 2, 2010Assignee: Roche Diagnostics Operations, Inc.Inventors: Guenter Frey, Carina Horn, Otto Gaa, Hans Kintzig, Hans-Ruediger Murawski
-
Publication number: 20080242962Abstract: The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.Type: ApplicationFiled: March 20, 2008Publication date: October 2, 2008Inventors: Bernd Roesicke, Karin Obermaier, Stefan Lindegger, Andreas Menke, Joerg Scherer, Karin Schwind, Otto Gaa, Gregor Bainczyk, Michael Marquant, Sandro Niederhauser, Michael Schoemaker, Martin Mueri
-
Publication number: 20080138906Abstract: The present invention pertains to a method for verifying usability of a test element on the basis of the relation of at least one control parameter measurable from the blank test field of a test element to a standard value for the at least one control parameter. In one embodiment, the method comprises determining the deviation between a first ratio calculated from a blank-field reference value measured for the control parameter and a first standard value, and a second ratio calculated from a blank-field control value and the first standard value, and rejecting a test element if the deviation is not within a predetermined tolerance range for the deviation.Type: ApplicationFiled: January 25, 2008Publication date: June 12, 2008Inventors: Otto Gaa, Gertrud Albrecht, Dieter Loch-Leroux
-
Publication number: 20050244981Abstract: The invention concerns a method for automatically differentiating between a sample liquid and a control liquid especially within the context of analytical measuring systems, wherein the presence of a special property of the control liquid and/or at least two criteria are used for the differentiation. In addition the invention concerns appropriate control liquids that are suitable for the new method.Type: ApplicationFiled: June 24, 2003Publication date: November 3, 2005Inventors: Guenter Frey, Carina Horn, Otto Gaa, Hans Kintzig, Hans-Ruediger Murawski